Modular Medical, Inc. director and officer Paul DiPerna filed a Form 4 on November 9, 2026, disclosing the acquisition of an option to purchase 150,000 shares of common stock on October 29, 2026.

Key Highlights

  • Transaction date: October 29, 2026, with the option to purchase common stock acquired at an exercise price of $1.72 per share.
  • Grant size: 150,000 shares of common stock underlie the option, acquired at a price of $0.00 to the reporting person.
  • Vesting schedule: According to the filing, 1/3rd of the shares vest on October 29, 2027, with the remaining shares vesting at 1/36th per month thereafter.
  • Expiration: The option expires on October 29, 2036.
  • Roles: Paul DiPerna is identified in the filing as a Director, and as President, Chief Financial Officer, and Treasurer of Modular Medical, Inc.
  • Beneficial ownership following transaction: 150,000 derivative securities (options to purchase common stock) reported as directly owned.

DiPerna Option Grant Details at Modular Medical

According to the Form 4 filed with the U.S. Securities and Exchange Commission, Paul DiPerna, who serves as President, Chief Financial Officer, and Treasurer as well as a Director of Modular Medical, Inc. (NASDAQ:MODD), acquired an option to purchase 150,000 shares of the company's common stock on October 29, 2026. The transaction code reported is "A," indicating acquisition. The exercise price of the derivative security is $1.72 per share, and the filing states the price of the derivative security to DiPerna was $0.00.

The filing specifies that the option shall vest as to 1/3rd of the shares on October 29, 2027, and as to 1/36th of the shares on a monthly basis thereafter, with an expiration date of October 29, 2036. Following the reported transaction, the filing reports total beneficial ownership of 150,000 options in this class of derivative security, held directly.

The filing notes, in accordance with Instruction 4 to Form 4, that column 9 reports only total beneficial ownership of the same "class" of derivative security, and that options with different exercise prices or vesting terms are not considered the same class. No non-derivative securities transactions were reported in Table I of this filing. The Form 4 was signed by James Sullivan as attorney-in-fact for Paul DiPerna and dated November 9, 2026.

What Was Disclosed

Paul DiPerna, a director and senior officer of Modular Medical, Inc., disclosed the acquisition of an option to purchase 150,000 shares of common stock at $1.72 per share, granted October 29, 2026, with a ten-year term and a multi-year vesting schedule.